Home > Insider Trading > Filing (0001562180-16-002637)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557883	Dermira Inc.	DERM	Pharmaceutical Preparations (2834)	273267680

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1620520	M. Christopher Griffith	C/O Dermira, Inc. 275 Middlefield Road, Suite 150 Menlo Park CA 94025	Vp Corp. Dev. & Strategy	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-06-13	287	$1.74	48,043	No	4	M	Direct
Common Stock	Acquisiton	2016-06-13	1,016	$1.22	49,059	No	4	M	Direct
Common Stock	Disposition	2016-06-13	4,405	$30.16	44,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to buy)	Disposition	2016-06-13	287	$0.00	287	$1.74
Common Stock	Employee Stock Options (Right to buy)	Disposition	2016-06-13	1,016	$0.00	1,016	$1.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,609		2024-02-06	No	4	M	Direct
55,706		2023-01-03	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan.
Includes prior ESPP purchases totaling 3,102 shares.
This transaction was executed in multiple trades at prices ranging from $29.86 to $30.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes prior ESPP purchases totaling 1,551 shares.
25% of the total shares underlying the option vested and became exercisable on February 9, 2015 (the one-year anniversary of the vesting commencement date) and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date.
25% of the total shares underlying the option vested and became exercisable on January 4, 2014 (the one-year anniversary of the vesting commencement date) and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date.